Multicentric Castleman Disease Clinical Trials

Massive Bio Cancer 2nd Opinion Blog 0 Comments
The Multicentric Castleman Disease Clinical Trials

Castleman disease (CD) is a rare disease of the lymph nodes and related tissues. Though CD is not officially a cancer, it behaves much like lymphoma. Multicentric Castleman disease clinical trials are focused on how to better detect and better treat this disease, so more patients have positive outcomes.

Multicentric Castleman disease clinical trials are responsible for all the current treatments for multicentric CD and are the only hope of developing new, more effective treatments with less side effects. CD is rare, so every chance to understand the disease’s process is important.

Read More

What is tumor profiling, and do I need it?

Cancer Clinical Trial Specialist Cancer 2nd Opinion Blog 0 Comments
What tumor profiling 1

Absolutely! Molecular profiling reveals the tumor’s behavior, give us clues on any weaknesses, and the best drugs that can target those weaknesses. But not all tumor profiling is the same, and different vendors can give very different reports. Massive Bio helps you keep them in check.

Smoking and Cancer

Cancer Clinical Trial Specialist Cancer 2nd Opinion Blog 0 Comments
Cancer 2nd Opinion

Smoking increases mortality rates by 40% in people who smoke fewer than 10 cigarettes daily, by 70% in people who smoke 10-19 per day, by ninety percent in people who smoke 20-39 per day, and by 120% in people smoking two packs or daily. Research from the Canadian Lung Association found that smoking kills between 40,000 – 45,000, over the number of deaths caused accidental poisoning, AIDS, murder, fires, by traffic injuries and suicide. 50% of smokers may die of illness. Tobacco related diseases kill almost 438,000 United States taxpayers per year or 1,200 per day, making it the major cause of preventable death in the U.S.

Based on WHO tobacco will kill this century. Those who’ve ever smoked tobacco have an one in ten chance of developing cancer of the lung. Of related disorders a people risk is proportionate to quantity and the time duration the person carries on to smoke. Nevertheless, if an individual successfully stops smoking their risks progressively decrease as the harm inflicted on their bodies is repaired. The benefits of stopping smoking are immediate: heart rate, blood pressure level, and temperature return to myocardial infarction risk decreases normal selection and circulation improves. Those under 40 are 5 times less unlikely to have a myocardial infarction if they smoke.

|Squamous cell lung carcinoma

Loss happens 2-3 times more frequently in smokers than in nonsmokers. The incidence of erection dysfunction is 85% higher in smokers than it’s in nonsmokers. Studies show that tobacco use contributes to many abortions among pregnant smokers. Both first hand and second hand smoke contribute an equal danger to the health of the fetus. There’s a significant correlation between Cot Death and smoking. A greater concentration of nicotine and cotinine is present in the lungs of such babies than in people who die of other causes. Many forms of cancer, especially cancer of the lung, cancer of the kidney, cancer of the larynx and neck and head, breast cancer, urinary bladder, esophagus, pancreas, and stomach. There’s evidence suggesting a higher risk of myeloid leukemia, squamous cell sinonasal cancer, liver cancer, cervical cancer, colorectal cancer after an extended latency, childhood cancers of the gallurinary bladder, adrenal gland and small intestine. Coronary disease Atherosclerosis Stroke Peripheral blood vessel disease Respiratory diseases Common cold and bronchitis Chronic obstructive pulmonary disease, emphysema and chronic bronchitis particularly Birth defects of pregnant smokers offspring Buerger’s disease Cataracts that can cause blindness Cognitive dysfunction higher risk of Alzheimer’s disease and decline in cognitive capabilities Reduced memory and cognitive capabilities in adolescent smokers Brain shrinkage Impotence.

We Put You First

Cancer Clinical Trial Specialist Cancer 2nd Opinion Blog 0 Comments

We know that you have many difficulties after being diagnosed with cancer 2nd opinion. We have various resources to support your fight against cancer.

We provide resources to explore different treatment options, clinical trial access and understand the latest therapies.

We review your case and provide a list of options from the more than 30,000 available clinical trials around the world.